Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 25 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C and Author is Smeeth, L.  [Clear All Filters]
2020
S. Wilkinson, Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., Douglas, I. J., and Tomlinson, L. A., “Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care”, Diabetes Obes Metab, 2020.
P. Bidulka, Iwagami, M., Mansfield, K. E., Kalogirou, F., Wong, A. Y. S., Douglas, I. J., Smeeth, L., Summers, C., and Tomlinson, L. A., “Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study”, Wellcome Open Res, vol. 5, p. 77, 2020.
A. D. Morgan, Sinnott, S. J., Smeeth, L., Minassian, C., and Quint, J., “Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study”, BJGP Open, 2020.
2019
F. Nissen, Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., and Quint, J. K., “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
S. J. Sinnott, Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., and Douglas, I. J., “The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data”, Pharmacoepidemiol Drug Saf, 2019.
K. Mansfield, Crellin, E., Denholm, R., Quint, J. K., Smeeth, L., Cook, S., and Herrett, E., “Completeness and validity of alcohol recording in general practice within the UK: a cross-sectional study”, BMJ Open, vol. 9, p. e031537, 2019.
C. I. Bloom, Douglas, I., Olney, J., D'Ancona, G., Smeeth, L., and Quint, J. K., “Cost saving of switching to equivalent inhalers and its effect on health outcomes”, Thorax, 2019.
2018
J. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., “Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink”, BMC Med, vol. 16, p. 116, 2018.
S. Wilkinson, Douglas, I., Stirnadel-Farrant, H., Fogarty, D., Pokrajac, A., Smeeth, L., and Tomlinson, L., “Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017”, BMJ Open, vol. 8, p. e022768, 2018.
M. Iwagami, Caplin, B., Smeeth, L., Tomlinson, L. A., and Nitsch, D., “Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data”, Br J Gen Pract, vol. 68, pp. e512-e523, 2018.
A. D. Morgan, Rothnie, K. J., Bhaskaran, K., Smeeth, L., and Quint, J. K., “Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data”, Thorax, vol. 73, pp. 877-879, 2018.
F. Nissen, Morales, D. R., Mullerova, H., Smeeth, L., Douglas, I. J., and Quint, J. K., “Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care”, Br J Gen Pract, vol. 68, pp. e775-e782, 2018.
2017
J. P. H. Wilding, Godec, T., Khunti, K., Pocock, S., Fox, R., Smeeth, L., Clauson, P., Fenici, P., Hammar, N., and Medina, J., “Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice.”, Diabetologia., vol. 60, p. S301, 2017.
2016
J. K. Quint, Millett, E. R., Joshi, M., Navaratnam, V., Thomas, S. L., Hurst, J. R., Smeeth, L., and Brown, J. S., “Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study”, Eur Respir J, vol. 47, pp. 186-93, 2016.
A. D. Morgan, Herrett, E., De Stavola, B. L., Smeeth, L., and Quint, J. K., “COPD disease severity and the risk of venous thromboembolic events: a matched case-control study”, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 899-908, 2016.
2015
K. J. Rothnie, Smeeth, L., Herrett, E., Pearce, N., Hemingway, H., Wedzicha, J., Timmis, A., and Quint, J. K., “Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease”, Heart, vol. 101, pp. 1103-10, 2015.
2014
S. L. Thomas, Minassian, C., Ganesan, V., Langan, S. M., and Smeeth, L., “Chickenpox and risk of stroke: a self-controlled case series analysis”, Clin Infect Dis, vol. 58, pp. 61-8, 2014.
R. Mathur, Bhaskaran, K., Chaturvedi, N., Leon, D. A., vanStaa, T., Grundy, E., and Smeeth, L., “Completeness and usability of ethnicity data in UK-based primary care and hospital databases”, J Public Health (Oxf), vol. 36, pp. 684-92, 2014.
2013
E. Herrett, Shah, A. D., Boggon, R., Denaxas, S., Smeeth, L., Van Staa, T., Timmis, A., and Hemingway, H., “Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study”, Bmj, vol. 346, p. f2350, 2013.
2012
I. J. Douglas, Evans, S. J., Hingorani, A. D., Grosso, A. M., Timmis, A., Hemingway, H., and Smeeth, L., “Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs”, Bmj, vol. 345, p. e4388, 2012.
2009
T. P. van Staa, Leufkens, H. G., Zhang, B., and Smeeth, L., “A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example”, PLoS Med, vol. 6, p. e1000194, 2009.
2007
I. J. Douglas, Cook, C., Chakravarthy, U., Hubbard, R., Fletcher, A. E., and Smeeth, L., “A case-control study of drug risk factors for age-related macular degeneration”, Ophthalmology, vol. 114, pp. 1164-9, 2007.
2005
L. Smeeth, Cook, C., Chakravarthy, U., Hubbard, R., and Fletcher, A. E., “A case control study of age related macular degeneration and use of statins”, Br J Ophthalmol, vol. 89, pp. 1171-5, 2005.
2003
L. Smeeth, Hubbard, R., and Fletcher, A. E., “Cataract and the use of statins: a case-control study”, Qjm, vol. 96, pp. 337-43, 2003.
2001
L. Smeeth, Hall, A. J., Fombonne, E., Rodrigues, L. C., Huang, X., and Smith, P. G., “A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology”, BMC Public Health, vol. 1, p. 2, 2001.
[Page last reviewed 6 April 2021]